The industry's more rigorous players are likely to pull further ahead over the coming years, not through any single ...
The industry's more rigorous players are likely to pull further ahead over the coming years, not through any single ...
We are expanding into the Middle East, Southeast Asia and Africa, where high musculoskeletal disease burden, growing private ...
Godavari Biorefineries Limited has received official approval from the Mexican Patent Office (Instituto Mexicano de la ...
Multi-year investment reinforces U.S. business expansion and adds to $7 billion in U.S. pharma R&D and manufacturing ...
He will lead the development of the company’s global biopharmaceutical CDMO platform spanning vaccines, antibody-drug ...
Aurobindo Pharma Limited has successfully completed its acquisition of the Contract Research Services business of A1 Biochem ...
FICCI's Bharat Life Sciences Award held in New Delhi recognises Dr. Jain's leadership in building a collaborative biopharma ecosystem through Mumbai Biocluster ...
Ayush services economy could scale to US $216–318 billion by 2047 subject to the strengthening of infrastructure, quality ...
Zealand Pharma’s investigational obesity drug survodutide delivered sustained weight loss and improved blood sugar control in ...
The data tracked patients for up to two years and found that the safety profile of LEQSELVI remained generally consistent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results